跳至主要内容
临床试验/NCT02707653
NCT02707653已完成不适用

Sublingual Misoprostol for the Treatment of Incomplete Abortion: Operations Research

Gynuity Health Projects2 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2016年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75
试验地点
2
主要终点
Percentage of women with complete uterine evacuation with study medication alone.

研究概览

简要总结

This study will investigate the use of misoprostol for first-line treatment of incomplete abortion at tertiary hospitals in Myanmar.

详细描述

This open-label feasibility study seeks to examine the potential of 400μg sublingual misoprostol for the treatment of incomplete abortion provided at tertiary hospitals.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 55 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • Confirmed incomplete abortion
  • No known contraindications to the study drug
  • Uterine size no larger than 12 weeks at time of presentation for care
  • No signs of severe infection, defined as at least two of the following:
  • foul smelling discharge,
  • fever > 38 degrees C, 100 degrees Fahrenheit
  • uterine tenderness.
  • No hemodynamic disturbances (pulse >110/min and systolic bp <100)
  • General good health
  • Agree to comply with study procedures including return for follow up visit
  • Live or work within one hour from a study site
  • Willing and able to sign consent forms

排除标准

  • Inability to provide informed consent

研究组 & 干预措施

Miso

Other

Misoprostol 400 s/l

干预措施: Misoprostol (Drug)

结局指标

主要结局

Percentage of women with complete uterine evacuation with study medication alone.

时间窗: 14 days

次要结局

  • Level of self-reported acceptability of treatment(7-14 days)
  • Percentage of women experiencing side effects(7-14 days)

研究者

发起方
Gynuity Health Projects
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验